HomeCompareCAH vs TROW

CAH vs TROW: Dividend Comparison 2026

CAH yields 0.99% · TROW yields 5.74%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TROW wins by $223.8K in total portfolio value
10 years
CAH
CAH
● Live price
0.99%
Share price
$206.31
Annual div
$2.04
5Y div CAGR
5.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$185.04
Full CAH calculator →
TROW
TROW
● Live price
5.74%
Share price
$89.03
Annual div
$5.11
5Y div CAGR
38.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$245.3K
Annual income
$104,467.83
Full TROW calculator →

Portfolio growth — CAH vs TROW

📍 TROW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAHTROW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAH + TROW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAH pays
TROW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAH
Annual income on $10K today (after 15% tax)
$83.95/yr
After 10yr DRIP, annual income (after tax)
$157.28/yr
TROW
Annual income on $10K today (after 15% tax)
$487.87/yr
After 10yr DRIP, annual income (after tax)
$88,797.66/yr
At 15% tax rate, TROW beats the other by $88,640.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAH + TROW for your $10,000?

CAH: 50%TROW: 50%
100% TROW50/50100% CAH
Portfolio after 10yr
$133.5K
Annual income
$52,326.44/yr
Blended yield
39.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CAH right now

CAH
Analyst Ratings
18
Buy
15
Hold
Consensus: Buy
Price Target
$252.33
+22.3% upside vs current
Range: $220.00 — $275.00
Altman Z
4.8
Piotroski
5/9
TROW
Analyst Ratings
8
Buy
24
Hold
6
Sell
Consensus: Hold
Price Target
$106.25
+19.3% upside vs current
Range: $94.00 — $115.00
Altman Z
7.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAH buys
0
TROW buys
0
No recent congressional trades found for CAH or TROW in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAHTROW
Forward yield0.99%5.74%
Annual dividend / share$2.04$5.11
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR5.6%38.2%
Portfolio after 10y$21.6K$245.3K
Annual income after 10y$185.04$104,467.83
Total dividends collected$1.4K$207.9K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$252.33$106.25

Year-by-year: CAH vs TROW ($10,000, DRIP)

YearCAH PortfolioCAH Income/yrTROW PortfolioTROW Income/yrGap
1← crossover$10,804$104.30$11,493$793.22$689.00TROW
2$11,672$111.21$13,475$1,177.49$1.8KTROW
3$12,607$118.57$16,202$1,783.11$3.6KTROW
4$13,616$126.40$20,105$2,769.00$6.5KTROW
5$14,704$134.73$25,950$4,438.01$11.2KTROW
6$15,877$143.59$35,165$7,398.65$19.3KTROW
7$17,142$153.02$50,576$12,949.45$33.4KTROW
8$18,504$163.04$78,172$24,055.20$59.7KTROW
9$19,973$173.70$131,665$48,021.60$111.7KTROW
10$21,557$185.04$245,350$104,467.83$223.8KTROW

CAH vs TROW: Complete Analysis 2026

CAHHealthcare

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Full CAH Calculator →

TROWStock

T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity and fixed income markets across the globe. It employs fundamental and quantitative analysis with a bottom-up approach. The firm utilizes in-house and external research to make its investments. It employs socially responsible investing with a focus on environmental, social, and governance issues. It makes investment in late-stage venture capital transactions and usually invests between $3 million and $5 million. The firm was previously known as T. Rowe Group, Inc. and T. Rowe Price Associates, Inc. T. Rowe Price Group, Inc. was founded in 1937 and is based in Baltimore, Maryland, with additional offices in Colorado Springs, Colorado; Owings Mills, Maryland; San Francisco, California; New York, New York; Philadelphia, Pennsylvania; Tampa, Florida; Toronto, Ontario; Hellerup, Denmark; Amsterdam, The Netherlands; Luxembourg, Grand Duchy of Luxembourg; Zurich, Switzerland; Dubai, United Arab Emirates; London, United Kingdom; Sydney, New South Wales; Hong Kong; Tokyo, Japan; Singapore; Frankfurt, Germany, Madrid, Spain, Milan, Italy, Stockholm, Sweden, Melbourne, Australia, and Amsterdam, Netherlands.

Full TROW Calculator →
📬

Get this CAH vs TROW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAH vs SCHDCAH vs JEPICAH vs OCAH vs KOCAH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.